WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: IBD 4, Signs and symptoms assessment scale includes Rectal bleeding (RB), Concepts (e.g. Mayo score) are denoted by solid round-edged rectangle, Concepts with open questions are denoted in red font, Repeated concepts/instances (e.g. Biopsy) are denoted by dotted outline, instance of concepts (e.g. 24 hour period) are denoted by solid square-edged rectangle, Responder analysis includes Improvement in endoscopic appearance of mucosa, Improvement in endoscopic appearance of mucosa is_measured_by Endoscopic assessment scale, Scoring of characteristics with subjective elements include Friability Score, Handling discrepencies occur_with Endoscopist, Signs and symptoms assessment scale has_pertinent_information Patient reported outcomes (PRO), Patient reported outcomes (PRO) summarized_by Standardized instructions, FDA Criteria for Efficacy endpoints for UC treatment are_assessed_at Protocol-specific timepoints, Therapeutic Efficacy Point are defined by Observation or Assessment, Responder analysis includes Signs and symptoms assessment scale, Standardized procedures account_for Scoring of characteristics with subjective elements, Main concepts (e.g. Clinical response) are denoted by Larger bold font with thicker outline, Scoring of characteristics with subjective elements include Other Scores, Clinical remission based_on Responder analysis, FDA Criteria for Efficacy endpoints for UC treatment include Clinical remission, Visual assessment of mucosal appearance measured_by Standardized procedures